Swiss biotech Nuclidium is gaining attention for its copper-based radioligand therapeutics and diagnostics, capitalizing on ...

Eli Lilly today announced a $4.5 billion investment to create the Lilly Medicine Foundry, a new center for advanced ...

Johnson & Johnson today released results of a landmark real-world head-to-head study showing that Erleada (apalutamide) ...

August was a quiet month for pharma dealmaking, with few major acquisitions from industry giants. Notably, Organon agreed to ...

US antivirals giant Gilead Sciences today announced that it has signed non-exclusive, royalty-free voluntary licensing ...

Privately-held UK biotech Curve Therapeutics today announced the further strengthening of its leadership team with the ...

Ferring Pharmaceuticals reported positive results from the OPTIMISE study, showing that a treat-to-target approach using ...

Shattuck Labs is reducing its workforce by 40%, bringing its employee count below 50, and discontinuing its SL-172154 program ...

UK-based biotech LoQus23 Therapeutics has raised £35 million ($43 million) in a Series A financing round led by Forbion, with ...

The BioIndustry Association (BIA) and Centre for Process Innovation (CPI) have published a report highlighting the UK's mRNA ...

Early Access Programs (EAPs) and Named Patient Programs (NPPs) provide a pathway for patients with life-threatening ...

Gritstone bio's stock dropped 62% after releasing interim Phase II data on its neoantigen immunotherapy, GRANITE, in ...